Global Shift in Obesity Care: WHO Endorses GLP-1 Drugs as Long-Term Treatment Option
By: The Trek News Desk In a landmark move, the World Health Organisation (WHO) has officially recommended the use of GLP-1–based medications for long-term obesity management in adults. The guidance signals a major shift in how the global health body categorises obesity, no longer as a simple “lifestyle issue,” but as a complex, preventable, and…